Post-stroke mood and emotional disturbances:Pharmacological therapy based on mechanisms

Journal of Stroke

Volumn 18, Issue 3, 2016, Pages 244-255

  Kim, Jong S ^a  

^a University of Ulsan   (South Korea)

Author keywords

Depression; Emotion; Serotonin; Stroke; Treatment

Indexed keywords

ANXIOLYTIC AGENT; CITALOPRAM; DEXTROMETHORPHAN PLUS QUINIDINE; FLUOXETINE; LAMOTRIGINE; MIRTAZAPINE; MODAFINIL; PLACEBO; REBOXETINE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

AGGRESSION; ANGER; ANXIETY; CEREBROVASCULAR ACCIDENT; COGNITIVE DEFECT; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; DEPRESSION; DRUG BIOAVAILABILITY; DRUG EFFICACY; EMOTIONAL DISORDER; EMOTIONAL INCONTINENCE; FATIGUE; HUMAN; META ANALYSIS (TOPIC); MOOD DISORDER; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PATHOPHYSIOLOGY; PREDICTION; PREVALENCE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SCORING SYSTEM; SYMPTOM; SYSTEMATIC REVIEW (TOPIC);

EID: 84990052930     PISSN: 22876391     EISSN: 22876405     Source Type: Journal    
DOI: 10.5853/jos.2016.01144     Document Type: Review

References (154)

1. Kim JS, Choi-Kwon S., Poststroke depression and emotional incontinence: Correlation with lesion location. Neurology 2000;54:1805-1810.
2. Kim JS, Choi-Kwon S, Kwon SU, Lee HJ, Park KA, Seo YS. Factors affecting the quality of life after ischemic stroke: young versus old patients. J Clin Neurol 2005;1:59-68.
3. Choi-Kwon S, Kim HS, Kwon SU, Kim JS. Factors affecting the burden on caregivers of stroke survivors in South Korea. Arch Phys Med Rehabil 2005;86:1043-1048.
4. Kotila M, Numminen H, Waltimo O, Kaste M. Post-stroke depression and functional recovery in a population-based stroke register. The Finnstroke study. Eur J Neurol 1999;6:309-312.
5. van de Weg FB, Kuik DJ, Lankhorst GJ. Post-stroke depression and functional outcome: a cohort study investigating the influence of depression on functional recovery from stroke. Clin Rehabil 1999;13:268-272.
6. Paolucci S, Antonucci G, Pratesi L, Traballesi M, Grasso MG, Lubich S. Poststroke depression and its role in rehabilitation of inpatients. Arch Phys Med Rehabil 1999;80:985-990.
7. Loong CK, Kenneth NK, Paulin ST. Post-stroke depression: Outcome following rehabilitation. Aust N Z J Psychiatry 1995; 29:609-614.
8. Gillen R, Tennen H, McKee TE, Gernert-Dott P, Affleck G. Depressive symptoms and history of depression predict rehabilitation efficiency in stroke patients. Arch Phys Med Rehabil 2001;82:1645-1649.
9. Liman TG, Heuschmann PU, Endres M, Floel A, Schwab S, Kolominsky-Rabas PL. Impact of low mini-mental status on health outcome up to 5 years after stroke: the erlangen stroke project. J Neurol 2012;259:1125-1130.
10. Burvill PW, Johnson GA, Jamrozik KD, Anderson CS, Stewart-Wynne EG, Chakera TM. Anxiety disorders after stroke: results from the Perth community stroke study. Br J Psychiatry 1995; 166:328-332.
11. Townend BS, Whyte S, Desborough T, Crimmins D, Markus R, Levi C, et al. Longitudinal prevalence and determinants of early mood disorder post-stroke. J Clin Neurosci 2007;14:429-434.
12. Choi-Kwon S, Han SW, Kwon SU, Kim JS. Poststroke fatigue: characteristics and related factors. Cerebrovasc Dis 2005;19: 84-90.
13. Naess H, Nyland HI, Thomassen L, Aarseth J, Myhr KM. Fatigue at long-term follow-up in young adults with cerebral infarction. Cerebrovasc Dis 2005;20:245-250.
14. Radman N, Staub F, Aboulafia-Brakha T, Berney A, Bogousslavsky J, Annoni JM. Poststroke fatigue following minor infarcts: A prospective study. Neurology 2012;79:1422-1427.
15. Pihlaja R, Uimonen J, Mustanoja S, Tatlisumak T, Poutiainen E. Post-stroke fatigue is associated with impaired processing speed and memory functions in first-ever stroke patients. J Psychosom Res 2014;77:380-384.
16. Andersen G, Christensen D, Kirkevold M, Johnsen SP. Post-stroke fatigue and return to work: a 2-year follow-up. Acta Neurol Scand 2012;125:248-253.
17. Noh SM, Chung SJ, Kim KK, Kang DW, Lim YM, Kwon SU, et al. Emotional disturbance in CADASIL: its impact on quality of life and caregiver burden. Cerebrovasc Dis 2014;37:188-194.
18. de Coster L, Leentjens AF, Lodder J, Verhey FR. The sensitivity of somatic symptoms in post-stroke depression: a discriminant analytic approach. Int J Geriatr Psychiatry 2005;20:358-362.
19. Hackett ML, Kohler S, O’Brien JT, Mead GE. Neuropsychiatric outcomes of stroke. Lancet Neurol 2014;13:525-534.
20. Dennis M, O’Rourke S, Lewis S, Sharpe M, Warlow C. Emotional outcomes after stroke: factors associated with poor outcome. J Neurol Neurosurg Psychiatry 2000;68:47-52.
21. Gainotti G, Marra C. Determinants and consequences of post-stroke depression. Curr Opin Neurol 2002;15:85-89.
22. Morrison V, Pollard B, Johnston M, MacWalter R. Anxiety and depression 3 years following stroke: demographic, clinical, and psychological predictors. J Psychosom Res 2005;59:209-213.
23. Nys GM, van Zandvoort MJ, van der Worp HB, de Haan EH, de Kort PL, Kappelle LJ. Early depressive symptoms after stroke: neuropsychological correlates and lesion characteristics. J Neurol Sci 2005;228:27-33.
24. Caeiro L, Ferro JM, Santos CO, Figueira ML. Depression in acute stroke. J Psychiatry Neurosci 2006;31:377-383.
25. Linden T, Blomstrand C, Skoog I. Depressive disorders after 20 months in elderly stroke patients: a case-control study. Stroke 2007;38:1860-1863.
26. Ferro JM, Caeiro L, Santos C. Poststroke emotional and behavior impairment: a narrative review. Cerebrovasc Dis 2009;27 1:197-203.
27. Hackett ML, Pickles K. Part i: Frequency of depression after stroke: an updated systematic review and meta-analysis of observational studies. Int J Stroke 2014;9:1017-1025.
28. Robinson RG, Spalletta G. Poststroke depression: a review. Can J Psychiatry 2010;55:341-349.
29. Astrom M, Adolfsson R, Asplund K. Major depression in stroke patients. A 3-year longitudinal study. Stroke 1993;24:976-982.
30. Kim JS Lee EJ, Chang DI, Park JH, Ahn SH, Cha JK, et al. Efficacy of early administration of escitalopram on post-stroke depressive/emotional symptoms and neurologic dysfunction: a multicenter, double blind, randomized, placebo-controlled study. Lancet Psychiatry 2016: in press.
31. Kutlubaev MA, Hackett ML. Part ii: Predictors of depression after stroke and impact of depression on stroke outcome: an updated systematic review of observational studies. Int J Stroke 2014;9:1026-1036.
32. Aben I, Denollet J, Lousberg R, Verhey F, Wojciechowski F, Honig A. Personality and vulnerability to depression in stroke patients: a 1-year prospective follow-up study. Stroke 2002; 33:2391-2395.
33. Starkstein SE, Robinson RG, Price TR. Comparison of cortical and subcortical lesions in the production of poststroke mood disorders. Brain 1987;110:1045-1059.
34. Bhogal SK, Teasell R, Foley N, Speechley M. Lesion location and poststroke depression: systematic review of the methodological limitations in the literature. Stroke 2004;35:794-802.
35. Morris PL, Robinson RG, Raphael B, Hopwood MJ. Lesion location and poststroke depression. J Neuropsychiatry Clin Neurosci 1996;8:399-403.
36. Carson AJ, MacHale S, Allen K, Lawrie SM, Dennis M, House A, et al. Depression after stroke and lesion location: A systematic review. Lancet 2000;356:122-126.
37. Shimoda K, Robinson RG. The relationship between poststroke depression and lesion location in long-term follow-up. Biol Psychiatry 1999;45:187-192.
38. Narushima K, Kosier JT, Robinson RG. A reappraisal of poststroke depression, intra-and inter-hemispheric lesion location using meta-analysis. J Neuropsychiatry Clin Neurosci 2003;15:422-430.
39. Barker-Collo SL. Depression and anxiety 3 months post stroke: Prevalence and correlates. Arch Clin Neuropsychol 2007;22: 519-531.
40. Brodaty H, Withall A, Altendorf A, Sachdev PS. Rates of depression at 3 and 15 months poststroke and their relationship with cognitive decline: the Sydney Stroke Study. Am J Geriatr Psychiatry 2007;15:477-486.
41. Carota A, Berney A, Aybek S, Iaria G, Staub F, Ghika-Schmid F, et al. A prospective study of predictors of poststroke depression. Neurology 2005;64:428-433.
42. Robinson RG, Jorge RE. Post-stroke depression: a review. Am J Psychiatry 2016;173:221-231.
43. Luijendijk HJ, Stricker BH, Wieberdink RG, Koudstaal PJ, Hofman A, Breteler MM, et al. Transient ischemic attack and incident depression. Stroke 2011;42:1857-1861.
44. Hackett ML, Anderson CS, House A, Halteh C. Interventions for preventing depression after stroke. Cochrane Database Syst Rev 2008:CD003689.
45. Hackett ML, Anderson CS, House A, Xia J. Interventions for treating depression after stroke. Cochrane Database Syst Rev 2008:CD003437.
46. Robinson RG, Jorge RE, Moser DJ, Acion L, Solodkin A, Small SL, et al. Escitalopram and problem-solving therapy for prevention of poststroke depression: a randomized controlled trial. JAMA 2008;299:2391-2400.
47. Tsai CS, Wu CL, Chou SY, Tsang HY, Hung TH, Su JA. Prevention of poststroke depression with milnacipran in patients with acute ischemic stroke: a double-blind randomized placebo-controlled trial. Int Clin Psychopharmacol 2011;26:263-267.
48. Quinn TJ, Paolucci S, Sunnerhagen KS, Sivenius J, Walker MF, Toni D, et al. Evidence-based stroke r-ehabilitation: an expanded guidance document from the european stroke organisation (eso) guidelines for management of ischaemic stroke and transient ischaemic attack 2008. J Rehabil Med 2009;41: 99-111.
49. Miller EL, Murray L, Richards L, Zorowitz RD, Bakas T, Clark P, et al. Comprehensive overview of nursing and interdisciplinary rehabilitation care of the stroke patient: a scientific statement from the american heart association. Stroke 2010;41: 2402-2448.
50. Castillo CS, Schultz SK, Robinson RG. Clinical correlates of early-onset and late-onset poststroke generalized anxiety. Am J Psychiatry 1995;152:1174-1179.
51. Schultz SK, Castillo CS, Kosier JT, Robinson RG. Generalized anxiety and depression. Assessment over 2 years after stroke. Am J Geriatr Psychiatry 1997;5:229-237.
52. Astrom M. Generalized anxiety disorder in stroke patients. A 3-year longitudinal study. Stroke 1996;27:270-275.
53. Campbell Burton CA, Murray J, Holmes J, Astin F, Greenwood D, Knapp P. Frequency of anxiety after stroke: a systematic review and meta-analysis of observational studies. Int J Stroke 2013;8:545-559.
54. Shimoda K, Robinson RG. Effects of anxiety disorder on impairment and recovery from stroke. J Neuropsychiatry Clin Neurosci 1998;10:34-40.
55. Starkstein SE, Cohen BS, Fedoroff P, Parikh RM, Price TR, Robinson RG. Relationship between anxiety disorders and depressive disorders in patients with cerebrovascular injury. Arch Gen Psychiatry 1990;47:246-251.
56. Campbell Burton CA, Holmes J, Murray J, Gillespie D, Lightbody CE, Watkins CL, et al. Interventions for treating anxiety after stroke. Cochrane Database Syst Rev 2011:CD008860.
57. Wilson SA. Original papers: Some problems in neurology. J Neurol Psychopathol 1924;4:299-333.
58. Cummings JL, Arciniegas DB, Brooks BR, Herndon RM, Lauterbach EC, Pioro EP, et al. Defining and diagnosing involuntary emotional expression disorder. CNS Spectr 2006;11:1-7.
59. Poeck K. Pathophysiology of emotional disorders associated with brain damage. In:Vinken PJ, Bruyn GW, ed. Handbook of Clinical Neurology. New York: Elsevier 1969:343-367
60. House A, Dennis M, Molyneux A, Warlow C, Hawton K. Emotionalism after stroke. BMJ 1989;298:991-994.
61. Allman P, Hope T, Fairburn CG. Crying following stroke. A report on 30 cases. Gen Hosp Psychiatry 1992;14:315-321.
62. Nieuwenhuis-Mark RE, van Hoek A, Vingerhoets A. Understanding excessive crying in neurologic disorders: nature, pathophysiology, assessment, consequences, and treatment. Cogn Behav Neurol 2008;21:111-123.
63. Morris PL, Robinson RG, Raphael B. Emotional lability after stroke. Aust N Z J Psychiatry 1993;27:601-605.
64. MacHale SM, Cavanagh JT, Bennie J, Carroll S, Goodwin GM, Lawrie SM. Diurnal variation of adrenocortical activity in chronic fatigue syndrome. Neuropsychobiology 1998;38:213-217.
65. Calvert T, Knapp P, House A. Psychological associations with emotionalism after stroke. J Neurol Neurosurg Psychiatry 1998; 65:928-929.
66. Kim JS. Post-stroke emotional incontinence after small lenticulocapsular stroke: correlation with lesion location. J Neurol 2002;249:805-810.
67. Tang WK, Chan SS, Chiu HF, Ungvari GS, Wong KS, Kwok TC. Emotional incontinence in chinese stroke patients--diagnosis, frequency, and clinical and radiological correlates. J Neurol 2004;251:865-869.
68. Tang WK, Chen YK, Lu JY, Mok VC, Xiang YT, Ungvari GS, et al. Microbleeds and post-stroke emotional lability. J Neurol Neurosurg Psychiatry 2009;80:1082-1086.
69. Kim JM, Stewart R, Kang HJ, Bae KY, Kim SW, Shin IS, et al. Associations of serotonergic genes with poststroke emotional incontinence. Int J Geriatr Psychiatry 2012;27:799-806.
70. Choi-Kwon S, Han K, Choi S, Suh M, Kim YJ, Song H, et al. Poststroke depression and emotional incontinence: factors related to acute and subacute stages. Neurology 2012;78: 1130-1137.
71. Ceccaldi M, Milandre L. A transient fit of laughter as the inaugural symptom of capsular-thalamic infarction. Neurology 1994;44:1762.
72. Kim JS. Pathologic laughter after unilateral stroke. J Neurol Sci 1997;148:121-125.
73. Parvizi J, Anderson SW, Martin CO, Damasio H, Damasio AR. Pathological laughter and crying: a link to the cerebellum. Brain 2001;124:1708-1719.
74. Pollack IF, Polinko P, Albright AL, Towbin R, Fitz C. Mutism and pseudobulbar symptoms after resection of posterior fossa tumors in children: incidence and pathophysiology. Neurosurgery 1995;37:885-893.
75. Schmahmann JD, Sherman JC. The cerebellar cognitive affective syndrome. Brain 1998;121 (4):561-579.
76. Levisohn L, Cronin-Golomb A, Schmahmann JD. Neuropsychological consequences of cerebellar tumour resection in children: cerebellar cognitive affective syndrome in a paediatric population. Brain 2000;123:1041-1050.
77. Parvizi J, Schiffer R. Exaggerated crying and tremor with a cerebellar cyst. J Neuropsychiatry Clin Neurosci 2007;19:187-190.
78. Parvizi J, Joseph J, Press DZ, Schmahmann JD. Pathological laughter and crying in patients with multiple system atrophy-cerebellar type. Mov Disord 2007;22:798-803.
79. Rabins PV, Arciniegas DB. Pathophysiology of involuntary emotional expression disorder. CNS Spectr 2007;12:17-22.
80. Choi-Kwon S, Kim JS. Poststroke emotional incontinence and decreased sexual activity. Cerebrovasc Dis 2002;13:31-37.
81. Andersen G, Ingeman-Nielsen M, Vestergaard K, Riis JO. Pathoanatomic correlation between poststroke pathological crying and damage to brain areas involved in serotonergic neurotransmission. Stroke 1994;25:1050-1052.
82. Murai T, Barthel H, Berrouschot J, Sorger D, von Cramon DY, Muller U. Neuroimaging of serotonin transporters in post-stroke pathological crying. Psychiatry Res 2003;123:207-211.
83. Wolf JK, Santana HB, Thorpy M. Treatment of “emotional incontinence” with levodopa. Neurology 1979;29:1435-1436.
84. Udaka F, Yamao S, Nagata H, Nakamura S, Kameyama M. Pathologic laughing and crying treated with levodopa. Arch Neurol 1984;41:1095-1096.
85. Brooks BR, Thisted RA, Appel SH, Bradley WG, Olney RK, Berg JE, et al. Treatment of pseudobulbar affect in ALS with dextromethorphan/quinidine: a randomized trial. Neurology 2004; 63:1364-1370.
86. Rogawski MA. Low affinity channel blocking (uncompetitive) NMDA receptor antagonists as therapeutic agents--toward an understanding of their favorable tolerability. Amino Acids 2000;19:133-149.
87. Panitch HS, Thisted RA, Smith RA, Wynn DR, Wymer JP, Achiron A, et al. Randomized, controlled trial of dextromethorphan/quinidine for pseudobulbar affect in multiple sclerosis. Ann Neurol 2006;59:780-787.
88. Bermack JE, Debonnel G. The role of sigma receptors in depression. J Pharmacol Sci 2005;97:317-336.
89. Hackett ML, Yang M, Anderson CS, Horrocks JA, House A. Pharmaceutical interventions for emotionalism after stroke. Cochrane Database Syst Rev 2010:CD003690.
90. Andersen G, Vestergaard K, Riis JO. Citalopram for post-stroke pathological crying. Lancet 1993;342:837-839.
91. Brown KW, Sloan RL, Pentland B. Fluoxetine as a treatment for post-stroke emotionalism. Acta Psychiatr Scand 1998;98: 455-458.
92. Burns A, Russell E, Stratton-Powell H, Tyrell P, O’Neill P, Baldwin R. Sertraline in stroke-associated lability of mood. Int J Geriatr Psychiatry 1999;14:681-685.
93. Murray V, von Arbin M, Bartfai A, Berggren AL, Landtblom AM, Lundmark J, et al. Double-blind comparison of sertraline and placebo in stroke patients with minor depression and less severe major depression. J Clin Psychiatry 2005;66:708-716.
94. Choi-Kwon S, Han SW, Kwon SU, Kang DW, Choi JM, Kim JS. Fluoxetine treatment in poststroke depression, emotional incontinence, and anger proneness: a double-blind, placebo-controlled study. Stroke 2006;37:156-161.
95. Ohkawa S, Mori E, Yamadori A. Treatment of pathological laughing with amitriptyline. Rinsho Shinkeigaku 1989;29:1183-1185.
96. Robinson RG, Parikh RM, Lipsey JR, Starkstein SE, Price TR. Pathological laughing and crying following stroke: validation of a measurement scale and a double-blind treatment study. Am J Psychiatry 1993;150:286-293.
97. Moller M, Andersen G. Inhibition of selective noradrenergic reuptake as treatment of pathological laughter. J Clin Psychopharmacol 2007;27:108-110.
98. Smith AG, Montealegre-Orjuela M, Douglas JE, Jenkins EA. Venlafaxine for pathological crying after stroke. J Clin Psychiatry 2003;64:731-732.
99. Kim SW, Shin IS, Kim JM, Lim SY, Yang SJ, Yoon JS. Mirtazapine treatment for pathological laughing and crying after stroke. Clin Neuropharmacol 2005;28:249-251.
100. Ramasubbu R. Lamotrigine treatment for post-stroke pathological laughing and crying. Clin Neuropharmacol 2003;26: 233-235.
101. Kim JS, Choi S, Kwon SU, Seo YS. Inability to control anger or aggression after stroke. Neurology 2002;58:1106-1108.
102. Chan KL, Campayo A, Moser DJ, Arndt S, Robinson RG. Aggressive behavior in patients with stroke: association with psychopathology and results of antidepressant treatment on aggression. Arch Phys Med Rehabil 2006;87:793-798.
103. Aybek S, Carota A, Ghika-Schmid F, Berney A, Melle GV, Guex P, et al. Emotional behavior in acute stroke: the lausanne emotion in stroke study. Cogn Behav Neurol 2005;18:37-44.
104. Greenop KR, Almeida OP, Hankey GJ, van Bockxmeer F, Lautenschlager NT. Premorbid personality traits are associated with post-stroke behavioral and psychological symptoms: a three-month follow-up study in Perth, western Australia. Int Psychogeriatr 2009;21:1063-1071.
105. Santos CO, Caeiro L, Ferro JM, Albuquerque R, Luisa Figueira M. Anger, hostility and aggression in the first days of acute stroke. Eur J Neurol 2006;13:351-358.
106. Choi-Kwon S, Han K, Cho KH, Choi S, Suh M, Nah HW, et al. Factors associated with post-stroke anger proneness in ischaemic stroke patients. Eur J Neurol 2013;20:1305-1310.
107. Coccaro EF, Kavoussi RJ. Fluoxetine and impulsive aggressive behavior in personality-disordered subjects. Arch Gen Psychiatry 1997;54:1081-1088.
108. Pollock BG, Mulsant BH, Rosen J, Mazumdar S, Blakesley RE, Houck PR, et al. A double-blind comparison of citalopram and risperidone for the treatment of behavioral and psychotic symptoms associated with dementia. Am J Geriatr Psychiatry 2007;15:942-952.
109. Fleminger S, Greenwood RJ, Oliver DL. Pharmacological management for agitation and aggression in people with acquired brain injury. Cochrane Database Syst Rev 2006:CD003299.
110. Glenn MB, Wroblewski B, Parziale J, Levine L, Whyte J, Rosenthal M. Lithium carbonate for aggressive behavior or affective instability in ten brain-injured patients. Am J Phys Med Rehabil 1989;68:221-226.
111. Staub F, Bogousslavsky J. Fatigue after stroke: a major but neglected issue. Cerebrovasc Dis 2001;12:75-81.
112. Choi-Kwon S, Kim JS. Poststroke fatigue: an emerging, critical issue in stroke medicine. Int J Stroke 2011;6:328-336.
113. Smith OR, van den Broek KC, Renkens M, Denollet J. Comparison of fatigue levels in patients with stroke and patients with end-stage heart failure: application of the fatigue assessment scale. J Am Geriatr Soc 2008;56:1915-1919.
114. Ingles JL, Eskes GA, Phillips SJ. Fatigue after stroke. Arch Phys Med Rehabil 1999;80:173-178.
115. van der Werf SP, van den Broek HL, Anten HW, Bleijenberg G. Experience of severe fatigue long after stroke and its relation to depressive symptoms and disease characteristics. Eur Neurol 2001;45:28-33.
116. Choi-Kwon S, Choi J, Kwon SU, Kang DW, Kim JS. Fluoxetine is not effective in the treatment of post-stroke fatigue: a double-blind, placebo-controlled study. Cerebrovasc Dis 2007; 23:103-108.
117. Michael KM, Allen JK, Macko RF. Fatigue after stroke: Relationship to mobility, fitness, ambulatory activity, social support, and falls efficacy. Rehabil Nurs 2006;31:210-217.
118. Winward C, Sackley C, Metha Z, Rothwell PM. A population-based study of the prevalence of fatigue after transient ischemic attack and minor stroke. Stroke 2009;40:757-761.
119. Christensen D, Johnsen SP, Watt T, Harder I, Kirkevold M, Andersen G. Dimensions of post-stroke fatigue: a two-year follow-up study. Cerebrovasc Dis 2008;26:134-141.
120. van de Port IG, Kwakkel G, Schepers VP, Heinemans CT, Lindeman E. Is fatigue an independent factor associated with activities of daily living, instrumental activities of daily living and health-related quality of life in chronic stroke? Cerebrovasc Dis 2007;23:40-45.
121. Tang WK, Chen YK, Mok V, Chu WC, Ungvari GS, Ahuja AT, et al. Acute basal ganglia infarcts in poststroke fatigue: an mri study. J Neurol 2010;257:178-182.
122. Lerdal A, Bakken LN, Rasmussen EF, Beiermann C, Ryen S, Pynten S, et al. Physical impairment, depressive symptoms and pre-stroke fatigue are related to fatigue in the acute phase after stroke. Disabil Rehabil 2011;33:334-342.
123. Duncan F, Wu S, Mead GE. Frequency and natural history of fatigue after stroke: a systematic review of longitudinal studies. J Psychosom Res 2012;73:18-27.
124. Glader EL, Stegmayr B, Asplund K. Poststroke fatigue: a 2-year follow-up study of stroke patients in Sweden. Stroke 2002;33: 1327-1333.
125. Appelros P. Prevalence and predictors of pain and fatigue after stroke: a population-based study. Int J Rehabil Res 2006; 29:329-333.
126. Snaphaan L, van der Werf S, de Leeuw FE. Time course and risk factors of post-stroke fatigue: a prospective cohort study. Eur J Neurol 2011;18:611-617.
127. Harbison JA, Walsh S, Kenny RA. Hypertension and daytime hypotension found on ambulatory blood pressure is associated with fatigue following stroke and TIA. QJM 2009;102:109-115.
128. Wang SS, Wang JJ, Wang PX, Chen R. Determinants of fatigue after first-ever ischemic stroke during acute phase. PLoS ONE 2014;9:e110037.
129. Naess H, Lunde L, Brogger J. The triad of pain, fatigue and depression in ischemic stroke patients: the Bergen stroke study. Cerebrovasc Dis 2012;33:461-465.
130. Chen YK, Qu JF, Xiao WM, Li WY, Weng HY, Li W, et al. Poststroke fatigue: risk factors and its effect on functional status and health-related quality of life. Int J Stroke 2015;10:506-512.
131. Sandberg O, Franklin KA, Bucht G, Gustafson Y. Sleep apnea, delirium, depressed mood, cognition, and disability after stroke. J Am Geriatr Soc 2001;49:391-397.
132. Park JY, Chun MH, Kang SH, Lee JA, Kim BR, Shin MJ. Functional outcome in poststroke patients with or without fatigue. Am J Phys Med Rehabil 2009;88:554-558.
133. Naess H, Lunde L, Brogger J, Waje-Andreassen U. Fatigue among stroke patients on long-term follow-up. The Bergen stroke study. J Neurol Sci 2012;312:138-141.
134. Tang WK, Chen YK, Liang HJ, Chu WC, Mok VC, Ungvari GS, et al. Subcortical white matter infarcts predict 1-year outcome of fatigue in stroke. BMC Neurology 2014;14:234.
135. Wu D, Wang L, Teng W, Huang K, Shang X. Correlation of fatigue during the acute stage of stroke with serum uric acid and glucose levels, depression, and disability. Eur Neurol 2014; 72:223-227.
136. Suh M, Choi-Kwon S, Kim JS. Sleep disturbances after cerebral infarction: role of depression and fatigue. J Stroke Cerebrovasc Dis 2014;23:1949-1955.
137. Naess H, Lunde L, Brogger J, Waje-Andreassen U. Post-stroke pain on long-term follow-up: the bergen stroke study. J Neurol 2010;257:1446-1452.
138. Hoang CL, Salle JY, Mandigout S, Hamonet J, Macian-Montoro F, Daviet JC. Physical factors associated with fatigue after stroke: an exploratory study. Top Stroke Rehabil 2012;19:369-376.
139. Duncan F, Greig C, Lewis S, Dennis M, MacLullich A, Sharpe M, et al. Clinically significant fatigue after stroke: a longitudinal cohort study. J Psychosom Res 2014;77:368-373.
140. van de Port IG, Kwakkel G, Bruin M, Lindeman E. Determinants of depression in chronic stroke: a prospective cohort study. Disabil Rehabil 2007;29:353-358.
141. Tang WK, Lu JY, Mok V, Ungvari GS, Wong KS. Is fatigue associated with suicidality in stroke? Arch Phys Med Rehabil 2011; 92:1336-1338.
142. Tseng BY, Billinger SA, Gajewski BJ, Kluding PM. Exertion fatigue and chronic fatigue are two distinct constructs in people post-stroke. Stroke 2010;41:1-5.
143. Jaracz K, Mielcarek L, Kozubski W. Clinical and psychological correlates of poststroke fatigue. Preliminary results. Neurol Neurochir Pol 2007;41:36-43.
144. Hubacher M, Calabrese P, Bassetti C, Carota A, Stocklin M, Penner IK. Assessment of post-stroke fatigue: the fatigue scale for motor and cognitive functions. Eur Neurol 2012;67: 377-384.
145. Johansson B, Ronnback L. Mental fatigue and cognitive impairment after an almost neurological recovered stroke. ISRN Psychiatry 2012;2012:686425.
146. Pardini M, Krueger F, Raymont V, Grafman J. Ventromedial prefrontal cortex modulates fatigue after penetrating traumatic brain injury. Neurology 2010;74:749-754.
147. Staub F, Annoni JM, Bogousslavsky J. Fatigue after stroke: a pilot study. Cerebrovasc Dis 2000;10:62.
148. Staub F, Annoni JM, Bogousslavsky J. Post-stroke fatigue: a major problem in “non-disabling” stroke. Cerebrovasc Dis 2002;13:96.
149. Carlsson GE, Moller A, Blomstrand C. Consequences of mild stroke in persons <75 years -- a 1-year follow-up. Cerebrovasc Dis 2003;16:383-388.
150. Ormstad H, Aass HC, Amthor KF, Lund-Sorensen N, Sandvik L. Serum cytokine and glucose levels as predictors of poststroke fatigue in acute ischemic stroke patients. J Neurol 2011;258: 670-676.
151. Karaiskos D, Tzavellas E, Spengos K, Vassilopoulou S, Paparrigopoulos T. Duloxetine versus citalopram and sertraline in the treatment of poststroke depression, anxiety, and fatigue. J Neuropsychiatry Clin Neurosci 2012;24:349-353.
152. Poulsen MB, Damgaard B, Zerahn B, Overgaard K, Rasmussen RS. Modafinil may alleviate poststroke fatigue: a randomized, placebo-controlled, double-blinded trial. Stroke 2015;46:3470-3477.
153. Ballon JS, Feifel D. A systematic review of modafinil: potential clinical uses and mechanisms of action. J Clin Psychiatry 2006; 67:554-566.
154. Choi-Kwon S, Choi J, Kwon SU, Kang DW, Kim JS. Fluoxetine improves the quality of life in patients with poststroke emotional disturbances. Cerebrovasc Dis 2008;26:266-271.